• The Korean Chronic Disease News
• /
• no.124
• /
• pp.6-6
• /
• 1991

• The Korean Nurse
• /
• v.31 no.5
• /
• pp.14-18
• /
• 1992

• The Korean Chronic Disease News
• /
• no.25
• /
• pp.8-8
• /
• 1982

• The Korean Chronic Disease News
• /
• no.95
• /
• pp.6-6
• /
• 1988

• The Korean Chronic Disease News
• /
• no.146
• /
• pp.16-16
• /
• 1993

• 월간산업보건
• /
• s.14
• /
• pp.47-47
• /
• 1989

• 건강소식
• /
• v.36 no.12
• /
• pp.30-31
• /
• 2012

동맥경화, 뇌졸중, 치매 등 혈관성 질환은 위험하기 때문에 사전 예방에 대한 관심이 높다. 혈관성 질환을 유발하는 원인은 다양한데, 그 중 호모시스테인은 심혈관계 질환을 일으키는 가장 강력한 원인이 되는 독성물질이다. 조금만 관심을 가지면 관리를 할 수 있다는 사실을 명심하자.

• The Monthly Diabetes
• /
• s.285
• /
• pp.23-29
• /
• 2013

당뇨병은 심근 경색의 재발 위험이나 심혈관 질환에 의한 사망 위험이 높다는 것은 잘 알려진 사실로 당뇨병 자체로도 관상동맥질환이 있는 것과 같이 대등한 위험인자로 취급하도록 권고되고 있다. 이러한 당뇨병에 이상지질혈증, 고혈압, 복부비만이 동반되어 있는 경우를 대사증후군으로 명명하기도 하며 심혈관질환 위험이 훨씬 증가한다.

• Korean Chemical Engineering Research
• /
• v.62 no.2
• /
• pp.133-141
• /
• 2024

Atherosclerosis, a disease with high morbidity and mortality worldwide, is a chronic inflammatory disease that is a major cause of cardiovascular diseases such as stroke and myocardial infarction. Atherosclerosis is characterized by the accumulation of lipid deposits in the arteries, forming atheromas. This leads to the narrowing of the arteries and thrombosis. Recently, the need to develop bio-derived anti-atherosclerotic materials has been highlighted with concerns about the side effects of synthetic therapeutics. Accordingly, related research (such as the discovery of biomaterials for the improvement and treatment of atherosclerosis and the identification of mechanisms) has been actively conducted. Biomaterials including polysaccharides, polyphenols, and coenzyme Q10 have been reported to inhibit or delay symptoms by modulating factors involved in the development of atherosclerosis. For biomaterials with superior activity, in vivo anti-atherosclerotic activity has been confirmed. In this review, the pathogenesis of atherosclerosis was investigated, and the current status and application prospects of biomaterials with anti-atherosclerotic activity were proposed.

• Journal of Chest Surgery
• /
• v.43 no.1
• /
• pp.25-32
• /
• 2010

Background: Patients with vascular diseases commonly have coronary artery disease and associated cardiac problems. Therefore, their underlying heart diseases may be induced or exacerbated after vascular surgery. The effectiveness of SPECT imaging, which is a relatively simple and non-invasive imaging modality, for assessing these underlying heart diseases is still controversial. This study was performed to evaluate the clinical effect of tests and treatment based on SPECT imaging prior to vascular surgery on the development of post-operation cardiac complications. Material and Method: Sixty three patients who were treated at Inje University Pusan Paik Hospital between April 2004 and September 2007 and who underwent adenosine infusion technetium-99m (Tc-99m) tetrofosmin SPECT imaging prior to vascular surgery were selected for this study and we retrospectively reviewed their records. Result: The sensitivity and specificity of detecting a perfusion defect on SPECT to predict the development of cardiac complications was relatively low at 41.2% and 52.2%, respectively. However when coronary angiographies were done on the patients with abnormal SPECT and this was followed by aggressive treatment such as coronary artery intervention and coronary artery bypass grafting based on the angiography results, there was a tendency for lower cardiac complication rates. Conclusion: SPECT imaging shows low effectiveness as a screening test for predicting cardiac complications after vascular surgery.